The global mycophenolic acid market was roughly USD 1.12 billion in 2025 and is projected to reach about USD 1.18 billion in 2026 and USD 1.91 billion by 2035, a 5.48% CAGR for 2026-2035. Growth is driven by more organ transplants, rising autoimmune disease rates such as lupus and rheumatoid arthritis, and higher demand for immunosuppressants.

Market Snapshot

  • Revenue, 2026: 1.18 Billion
  • Forecast, 2035: 1.91 Billion
  • CAGR, 2026-2035: 5.48%
  • Report Coverage: Global

Key Companies

  • HBC Chem
  • Shanghai Missyou Chemical
  • Suzhou Lixin Pharmaceutical
  • Hangzhou Dingyanchem
  • Taizhou Creating Chemical
  • Hubei Yikangyuan Chemical
  • Henan Coreychem
  • Chongqing Daxin Pharmaceutical
  • Shandong United-Rising Pharmaceutical
  • Others

About Healthcare Foresights

Healthcare Foresights provides market research and consulting across the healthcare and life sciences industry, combining industry research, analytical expertise and technology-enabled solutions to help companies, investors and decision-makers identify opportunities and drive growth. For the full report, customization or a sample, contact our team.